Immunogenicity of golimumab and its clinical relevance in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Leu, Jocelyn H; Adedokun, Omoniyi J; Gargano, Cynthia; Hsia, Elizabeth C; Xu, Zhenhua; Shankar, Gopi

Leu, Jocelyn H; Adedokun, Omoniyi J; Gargano, Cynthia; Hsia, Elizabeth C; Xu, Zhenhua; Shankar, Gopi.

Afiliação

Leu JH; Global Clinical Pharmacology, Janssen Research & Development, LLC, Spring House, PA, USA.
Adedokun OJ; Global Clinical Pharmacology, Janssen Research & Development, LLC, Spring House, PA, USA.
Gargano C; Clinical Biostatistics, Janssen Research & Development, LLC, Spring House, PA, USA.
Hsia EC; Immunology, Janssen Research & Development, LLC, Spring House, PA, USA.
Xu Z; Global Clinical Pharmacology, Janssen Research & Development, LLC, Spring House, PA, USA.
Shankar G; Biologics Development Sciences, Janssen Research & Development, LLC, Spring House, PA, USA.

Rheumatology (Oxford) ; 58(3): 441-446, 2019 03 01.

Article em En | MEDLINE | ID: mdl-30412238

Assuntos

Anticorpos Monoclonais/uso terapêutico; Antirreumáticos/uso terapêutico; Artrite Psoriásica/tratamento farmacológico; Artrite Reumatoide/tratamento farmacológico; Espondilite Anquilosante/tratamento farmacológico; Artrite Psoriásica/imunologia; Artrite Reumatoide/imunologia; Humanos; Espondilite Anquilosante/imunologia; Resultado do Tratamento

Palavras-chave

ankylosing spondylitis; anti-drug antibodies; drug-tolerant enzyme immunoassay; golimumab; psoriatic arthritis; rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Espondilite Anquilosante / Artrite Psoriásica / Antirreumáticos / Anticorpos Monoclonais Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google